{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T05:19:13Z","timestamp":1778563153707,"version":"3.51.4"},"reference-count":84,"publisher":"Bentham Science Publishers Ltd.","issue":"44","funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["310019\/2016-9"],"award-info":[{"award-number":["310019\/2016-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPD"],"published-print":{"date-parts":[[2020,1,9]]},"abstract":"<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>Due to their versatile biological activity, Azoles are widely studied in pharmacochemistry. It is possible\nto use them in many applications and in studies aimed at discovering antiparasitic, antineoplastic, antiviral,\nantimicrobial compounds; and in the production of materials for treatment of varied pathologies. Based on their\nbiological activity, our review presents several studies that involve this class of organic compounds. A bibliographic\nsurvey of this type can effectively contribute to pharmaceutical sciences, stimulating the discovery of new\ncompounds, and structural improvements to biological profiles of interest. In this review, articles are discussed\ninvolving the synthesis of new compounds and chemoinformatic contributions. Current applications of azoles in\nboth the pharmaceutical and agri-business sectors are well known, yet as this research highlights, azole compounds\ncan also bring important contributions to the fight against many diseases. Among the heterocyclics, azoles\nare increasingly studied by research groups around the world for application against tuberculosis, HIV, fungal and\nbacterial infections; and against parasites such as leishmaniasis and trypanosomiasis. Our hope is that this work\nwill help arouse the interest of research groups planning to develop new bioactives to fight against these and\nother diseases.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1381612825666191125090700","type":"journal-article","created":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T11:14:15Z","timestamp":1574680455000},"page":"4702-4716","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The Azoles in Pharmacochemistry: Perspectives on the Synthesis of New Compounds and Chemoinformatic Contributions"],"prefix":"10.2174","volume":"25","author":[{"given":"J\u00e9ssika","family":"de Oliveira Viana","sequence":"first","affiliation":[{"name":"Natural and Synthetic Bioactive Products Program (PgPNSB), Health Sciences Center, Federal University of Para\u00edba, Jo\u00e3o Pessoa- PB, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex France Messias","family":"Monteiro","sequence":"additional","affiliation":[{"name":"Natural and Synthetic Bioactive Products Program (PgPNSB), Health Sciences Center, Federal University of Para\u00edba, Jo\u00e3o Pessoa- PB, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Maria Barbosa","family":"Filho","sequence":"additional","affiliation":[{"name":"Natural and Synthetic Bioactive Products Program (PgPNSB), Health Sciences Center, Federal University of Para\u00edba, Jo\u00e3o Pessoa- PB, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1866-4107","authenticated-orcid":true,"given":"Luciana","family":"Scotti","sequence":"additional","affiliation":[{"name":"Natural and Synthetic Bioactive Products Program (PgPNSB), Health Sciences Center, Federal University of Para\u00edba, Jo\u00e3o Pessoa- PB, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4863-8057","authenticated-orcid":true,"given":"Marcus Tullius","family":"Scotti","sequence":"additional","affiliation":[{"name":"Natural and Synthetic Bioactive Products Program (PgPNSB), Health Sciences Center, Federal University of Para\u00edba, Jo\u00e3o Pessoa- PB, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/nature13384","volume":"510","author":"Hopkinson M.N.","year":"2014","unstructured":"Hopkinson M.N.; Richter C.; Schedler M.; Glorius F.; An overview of N-heterocyclic carbenes. Nature 2014,510(7506),485-496","journal-title":"Nature"},{"key":"ref=2","first-page":"1","volume":"2","author":"Selvam TP","year":"2012","unstructured":"Selvam TP; James CR; Dniandev PV; Valzita SK;  A mini review of pyrimidine and fuse pyrimidine marketed drugs Res Pharm 2012,2,1-9","journal-title":"A mini review of pyrimidine and fuse pyrimidine marketed drugs Res Pharm"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1016\/j.bmc.2009.04.032","volume":"17","author":"Shankar R.","year":"2009","unstructured":"Shankar R.; Chakravarti B.; Singh U.S.; Synthesis and biological evaluation of 3,4,6-triaryl-2-pyranones as a potential new class of anti-breast cancer agents. Bioorg Med Chem 2009,17(11),3847-3856","journal-title":"Bioorg Med Chem"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.cbpa.2010.02.018","volume":"14","author":"Welsch M.E.","year":"2010","unstructured":"Welsch M.E.; Snyder S.A.; Stockwell B.R.; Privileged scaffolds for library design and drug discovery. Curr Opin Chem Biol 2010,14(3),347-361","journal-title":"Curr Opin Chem Biol"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1590\/S0100-40422008000500050","volume":"31","author":"Netto A.V.G.","year":"2008","unstructured":"Netto A.V.G.; Frem R.C.G.; Mauro A.E.; Supramolecular chemistry of pyrazolyl complexes. Quim Nova 2008,31(5),1208-1217","journal-title":"Quim Nova"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"8482","DOI":"10.1016\/j.bmc.2008.08.024","volume":"16","author":"Singh U.S.","year":"2008","unstructured":"Singh U.S.; Shankar R.; Kumar A.; Synthesis and biological evaluation of indolyl bisphosphonates as anti-bone resorptive and anti-leishmanial agents. Bioorg Med Chem 2008,16(18),8482-8491","journal-title":"Bioorg Med Chem"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.ejmech.2005.07.002","volume":"40","author":"Foroumadi A.","year":"2005","unstructured":"Foroumadi A.; Emami S.; Pournourmohammadi S.; Kharazmi A.; Shafiee A.; Synthesis and in vitro leishmanicidal activity of 2-(1-methyl-5-nitro-1H-imidazol-2-yl)-5-substituted-1,3,4-thiadiazole derivatives. Eur J Med Chem 2005,40(12),1346-1350","journal-title":"Eur J Med Chem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1470-9465.2004.00841.x","volume":"10","author":"Maertens J.A.","year":"2004","unstructured":"Maertens J.A.; History of the development of azole derivatives. Clin Microbiol Infect 2004,10(Suppl. 1),1-10","journal-title":"Clin Microbiol Infect"},{"key":"ref=9","first-page":"85","volume":"86","author":"Kelemen H.","year":"2016","unstructured":"Kelemen H.; Orgovan G.; Szekely-Szentmiklosi B.; The pharmaceutical chemistry of azole antifungals. Acta Pharm Hung 2016,86(3),85-98","journal-title":"Acta Pharm Hung"},{"key":"ref=10","first-page":"1076","volume":"3","author":"Shrivastava A.","year":"2016","unstructured":"Shrivastava A.; Chakraborty A.K.; Upmanyu N.; Recent progress in chemistry and biology of indazole and its derivatives: a brief review. Austin J Anal Pharm Chem 2016,3(4),1076","journal-title":"Austin J Anal Pharm Chem"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2174\/1871520615666150520144217","volume":"16","author":"Sidhu J.S.","year":"2016","unstructured":"Sidhu J.S.; Singla R.; Mayank, Jaitak V. Indole derivatives as anticancer agents for breast cancer therapy: a review. Anticancer Agents Med Chem 2016,16(2),160-173","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1021\/acs.jmedchem.6b01392","volume":"60","author":"Travelli C.","year":"2017","unstructured":"Travelli C.; Aprile S.; Rahimian R.; Identification of novel triazole-based nicotinamide phosphoribosyltransferase (NAMPT) inhibitors endowed with antiproliferative and antiinflammatory activity. J Med Chem 2017,60(5),1768-1792","journal-title":"J Med Chem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/poc.610031006","volume":"3","author":"Ebert C.","year":"1990","unstructured":"Ebert C.; Elguero J.; Musumarra G.; Effects of the heteroaromatic moiety on spectroscopic properties, pKa and reactivity of azoles: a chemometric study. J Phys Org Chem 1990,3(10),651-658","journal-title":"J Phys Org Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1002\/ejoc.200800227","volume":"24","author":"Schmidt A.","year":"2008","unstructured":"Schmidt A.; Beutler A.; Snovydovych B.; Recent advances in the chemistry of indazoles. Eur J Org Chem 2008,24,4073-4095","journal-title":"Eur J Org Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"869","DOI":"10.2174\/138955705774329564","volume":"5","author":"Cerecetto H.","year":"2005","unstructured":"Cerecetto H.; Gerpe A.; Gonz\u00e1lez M.; Ar\u00e1n V.J.; de Oc\u00e1riz C.O.; Pharmacological properties of indazole derivatives: recent developments. Mini Rev Med Chem 2005,5(10),869-878","journal-title":"Mini Rev Med Chem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.ejmech.2014.11.029","volume":"90","author":"Gaikwad D.D.","year":"2015","unstructured":"Gaikwad D.D.; Chapolikar A.D.; Devkate C.G.; Synthesis of indazole motifs and their medicinal importance: an overview. Eur J Med Chem 2015,90,707-731","journal-title":"Eur J Med Chem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"4632","DOI":"10.1016\/j.tetlet.2017.10.070","volume":"58","author":"Angapelly S.","year":"2017","unstructured":"Angapelly S.; Ramya P.S.; SunithaRani R, Kumar CG, Kamal A, Arifuddin M. Ultrasound assisted, VOSO4 catalyzed synthesis of 4-thiazolidinones: Antimicrobial evaluation of indazole-4-thiazolidinone derivatives. Tetrahedron Lett 2017,58(49),4632-4637","journal-title":"Tetrahedron Lett"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.saa.2014.06.134","volume":"135","author":"Gautam D.","year":"2015","unstructured":"Gautam D.; Chaudhary R.P.; Synthesis, structure and antimicrobial evaluation of new 3,3a,4,5-tetrahydro-2H-benzo[g]indazol-2-yl-thiazol-4(5H)-ones. Spectrochim Acta A Mol Biomol Spectrosc 2015,135,219-226","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/jhet.2540","volume":"54","author":"Ghelani S.M.","year":"2017","unstructured":"Ghelani S.M.; Khunt H.R.; Naliapara Y.T.; Design, synthesis, characterization, and antimicrobial screening of novel indazole bearing oxadiazole derivatives. J Heterocycl Chem 2017,54(1),65-70","journal-title":"J Heterocycl Chem"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.3390\/molecules22111864","volume":"22","author":"Villanueva J.P.","year":"2017","unstructured":"Villanueva J.P.; Mulia L.Y.; S\u00e1nchez I.S.; Synthesis and biological evaluation of 2H-indazole derivatives: towards antimicrobial and anti-inflammatory dual agents. Molecules 2017,22(11),1864","journal-title":"Molecules"},{"key":"ref=21","first-page":"1","volume":"6","author":"Maheta J.G.","year":"2016","unstructured":"Maheta J.G.; Gol R.M.; Barot V.M.; Synthesis of novel (2H)indazole scaffold as an antimicrobial and anti-tubercular agent. Chem Bio Interface 2016,6,1","journal-title":"Chem Bio Interface"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.cclet.2015.01.008","volume":"26","author":"Napoleon A.A.","year":"2015","unstructured":"Napoleon A.A.; Khan F.R.N.; Jeong E.D.; Chung E.H.; Potential anti-tubercular agents: hexahydro-3-phenyl indazol-2-yl(pyridin-4-yl)methanones from anti-tubercular drug isoniazid and bis(substituted-benzylidene)cycloalkanones. Chin Chem Lett 2015,26(5),567-571","journal-title":"Chin Chem Lett"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"4867","DOI":"10.1021\/acs.jmedchem.6b00211","volume":"59","author":"Haile P.A.","year":"2016","unstructured":"Haile P.A.; Votta B.J.; Marquis R.W.; The identification and pharmacological characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a highly potent and selective inhibitor of RIP2 kinase. J Med Chem 2016,59(10),4867-4880","journal-title":"J Med Chem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s12039-015-0792-3","volume":"127","author":"Reddy A.V.","year":"2015","unstructured":"Reddy A.V.; Gogireddy S.; Dubey P.K.; Reddy M.; Design, synthesis and characterization of 1 H-pyridin-4-yl-3, 5-disubstituted indazoles and their anti-inflammatory and analgesic activity. J Chem Sci 2015,127(3),433-438","journal-title":"J Chem Sci"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1016\/j.bmcl.2017.10.041","volume":"27","author":"Chen T.","year":"2017","unstructured":"Chen T.; Sorna V.; Choi S.; Fragment-based design, synthesis, biological evaluation, and SAR of 1H-benzo[d]imidazol-2-yl)-1H-indazol derivatives as potent PDK1 inhibitors. Bioorg Med Chem Lett 2017,27(24),5473-5480","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"3782","DOI":"10.1016\/j.bmcl.2017.06.068","volume":"27","author":"Cui J.","year":"2017","unstructured":"Cui J.; Peng X.; Gao D.; Dai Y.; Ai J.; Li Y.; Optimization of 1H-indazol-3-amine derivatives as potent fibroblast growth factor receptor inhibitors. Bioorg Med Chem Lett 2017,27(16),3782-3786","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"4968","DOI":"10.1016\/j.bmc.2014.06.027","volume":"22","author":"Laufer R.","year":"2014","unstructured":"Laufer R.; Ng G.; Liu Y.; Discovery of inhibitors of the mitotic kinase TTK based on N-(3-(3-sulfamoylphenyl)-1H-indazol-5-yl)-acetamides and carboxamides. Bioorg Med Chem 2014,22(17),4968-4997","journal-title":"Bioorg Med Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"4625","DOI":"10.1016\/j.bmcl.2016.08.063","volume":"26","author":"Li S.W.","year":"2016","unstructured":"Li S.W.; Liu Y.; Sampson P.B.; Design and optimization of (3-aryl-1H-indazol-6-yl)spiro[cyclopropane-1,3\u2032-indolin]-2\u2032-ones as potent PLK4 inhibitors with oral antitumor efficacy. Bioorg Med Chem Lett 2016,26(19),4625-4630","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"27737","DOI":"10.1039\/C7RA02518A","volume":"7","author":"Liu Z.","year":"2017","unstructured":"Liu Z.; Lei Q.; Wei W.; Synthesis and biological evaluation of (E)-4-(3-arylvinyl-1 H-indazol-6-yl)pyrimidin-2-amine derivatives as PLK4 inhibitors for the treatment of breast cancer. RSC Advances 2017,7(44),27737-27746","journal-title":"RSC Advances"},{"key":"ref=30","first-page":"433","volume":"95","author":"Rudavatha D.","year":"2018","unstructured":"Rudavatha D.; Sreenivasulub R.; Pinapatia S.R.; Raju R.R.; Synthesis and anticancer evaluation of indazole-aryl hydrazide-hydrazone derivatives. J Indian Chem Soc 2018,95(4),433-438","journal-title":"J Indian Chem Soc"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"5582","DOI":"10.1039\/C7NJ00843K","volume":"41","author":"Sudhapriya N.","year":"2017","unstructured":"Sudhapriya N.; Balachandran C.; Awale S.; Perumal P.T.; Sn(ii)-mediated facile approach for the synthesis of 2-aryl-2 H-indazole-3-phosphonates and their anticancer activities. New J Chem 2017,41(13),5582-5594","journal-title":"New J Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ejmech.2017.10.008","volume":"141","author":"Sun Y.","year":"2017","unstructured":"Sun Y.; Shan Y.; Li C.; Discovery of novel anti-angiogenesis agents. Part 8: Diaryl thiourea bearing 1H-indazole-3-amine as multi-target RTKs inhibitors. Eur J Med Chem 2017,141,373-385","journal-title":"Eur J Med Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.bioorg.2018.10.071","volume":"82","author":"Elsayed N.M.Y.","year":"2019","unstructured":"Elsayed N.M.Y.; Serya R.A.T.; Tolba M.F.; Design, synthesis, biological evaluation and dynamics simulation of indazole derivatives with antiangiogenic and antiproliferative anticancer activity. Bioorg Chem 2019,82,340-359","journal-title":"Bioorg Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"4694","DOI":"10.1016\/j.bmc.2014.07.012","volume":"22","author":"Cheng M.F.","year":"2014","unstructured":"Cheng M.F.; Ou L.C.; Chen S.C.; Discovery, structure-activity relationship studies, and anti-nociceptive effects of 1-phenyl-3,6,6-trimethyl-1,5,6,7-tetrahydro-4H-indazol-4-one as novel opioid receptor agonists. Bioorg Med Chem 2014,22(17),4694-4703","journal-title":"Bioorg Med Chem"},{"key":"ref=35","first-page":"952","volume":"126","author":"Chao P.K.","year":"2017","unstructured":"Chao P.K.; Ueng S.H.; Ou L.C.; 1-(2, 4-Dibromophenyl)-3, 6, 6-trimethyl-1, 5, 6, 7-tetrahydro-4H-indazol-4-oneA novel opioid receptor agonist with less accompanying gastrointestinal dysfunction than morphine. J Amer Soc Anesthes 2017,126(5),952-966","journal-title":"J Amer Soc Anesthes"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1021\/acs.jnatprod.6b00057","volume":"79","author":"Wang H.","year":"2016","unstructured":"Wang H.; Hesek D.; Lee M.; The natural product essramycin and three of its isomers are devoid of antibacterial activity. J Nat Prod 2016,79(4),1219-1222","journal-title":"J Nat Prod"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1517\/13543776.2014.999764","volume":"25","author":"Kamal A.","year":"2015","unstructured":"Kamal A.; Syed M.A.H.; Mohammed S.M.; Therapeutic potential of benzothiazoles: a patent review (2010 - 2014). Expert Opin Ther Pat 2015,25(3),335-349","journal-title":"Expert Opin Ther Pat"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jhazmat.2013.04.025","volume":"258-259","author":"Cassani S.","year":"2013","unstructured":"Cassani S.; Kovarich S.; Papa E.; Roy P.P.; van der Wal L.; Gramatica P.; Daphnia and fish toxicity of (benzo)triazoles: validated QSAR models, and interspecies quantitative activity-activity modelling. J Hazard Mater 2013,258-259,50-60","journal-title":"J Hazard Mater"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/ardp.201300344","volume":"347","author":"Bekircan O.","year":"2014","unstructured":"Bekircan O.; Mente\u015fe E.; \u00dclker S.; Kucuk C.; Synthesis of some new 1,2,4-triazole derivatives starting from 3-(4-chlorophenyl)-5-(4-methoxybenzyl)-4H-1,2,4-triazol with anti-lipase and anti-urease activities. Arch Pharm (Weinheim) 2014,347(6),387-397","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=40","volume":"47","author":"Praveena K.S.S.","year":"2015","unstructured":"Praveena K.S.S.; Murthy N.Y.S.; Pal S.; Syntheses and biological activities of 1, 4-Disubstituted-1, 2, 3-triazoles. ChemInform 2015,47(13)","journal-title":"ChemInform"},{"key":"ref=41","first-page":"1","volume":"95","author":"Haider S.","year":"2014","unstructured":"Haider S.; Alam M.S.; Hamid H.; 1,2,3-Triazoles: scaffold with medicinal significance. Inflamm Cell Signal 2014,95,1-12","journal-title":"Inflamm Cell Signal"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ejmech.2014.01.009","volume":"74","author":"Zou Y.","year":"2014","unstructured":"Zou Y.; Yu S.; Li R.; Synthesis, antifungal activities and molecular docking studies of novel 2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl dithiocarbamates. Eur J Med Chem 2014,74,366-374","journal-title":"Eur J Med Chem"},{"key":"ref=43","first-page":"6658","volume":"43","author":"Obot I.B.","year":"2012","unstructured":"Obot I.B.; Johnson A.S.; Ab initio, DFT and TD-DFT electronic absorption spectra investigations on 3,5-Diamino-1,2,4-triazole. Comput Chem 2012,43,6658-6661","journal-title":"Comput Chem"},{"key":"ref=44","author":"Alves R.M.A.","year":"2016","unstructured":"Alves R.M.A.; Mota S.; Barata C.;  Carboxylic acid transportes Jen1 and Jen2 affect Candida albicans biofilms\u2019 formation and susceptibility to fluconazole 2016","journal-title":"Carboxylic acid transportes Jen1 and Jen2 affect Candida albicans biofilms\u2019 formation and susceptibility to fluconazole"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1093\/cid\/civ571","volume":"61","author":"Miceli M.H.","year":"2015","unstructured":"Miceli M.H.; Kauffman C.A.; Isavuconazole: a new broad-spectrum triazole antifungal agent. Clin Infect Dis 2015,61(10),1558-1565","journal-title":"Clin Infect Dis"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s40265-013-0168-2","volume":"74","author":"Zhanel G.G.","year":"2014","unstructured":"Zhanel G.G.; Chung P.; Adam H.; Ceftolozane\/tazobactam: a novel cephalosporin\/\u03b2-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilli. Drugs 2014,74(1),31-51","journal-title":"Drugs"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1134\/S1068162016030043","volume":"42","author":"Ashok D.","year":"2016","unstructured":"Ashok D.; Ravi S.; Lakshmi B.V.; Ganesh A.; Adam S.; Microwave assisted synthesis of (E)-1-(2-((1-benzyl-1H-1, 2, 3-triazol-4-yl)methoxy)phenyl)-3-(9-ethyl-9H-carbazol-3-yl)prop-2-en-1-ones and their antimicrobial activity. Russ J Bioorganic Chem 2016,42(3),323-331","journal-title":"Russ J Bioorganic Chem"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jscs.2015.03.003","volume":"21","author":"Jadhav R.P.","year":"2017","unstructured":"Jadhav R.P.; Raundal H.N.; Patil A.A.; Bobade V.D.; Synthesis and biological evaluation of a series of 1, 4-disubstituted 1, 2, 3-triazole derivatives as possible antimicrobial agents. J Saudi Chem Soc 2017,21(2),152-159","journal-title":"J Saudi Chem Soc"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1016\/j.bmcl.2016.03.059","volume":"26","author":"Naidu K.M.","year":"2016","unstructured":"Naidu K.M.; Srinivasarao S.; Agnieszka N.; Ewa A.K.; Kumar M.M.K.; Chandra Sekhar K.V.; Seeking potent anti-tubercular agents: Design, synthesis, anti-tubercular activity and docking study of various ((triazoles\/indole)-piperazin-1-yl\/1,4-diazepan-1-yl)benzo[d]isoxazole derivatives. Bioorg Med Chem Lett 2016,26(9),2245-2250","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jscs.2012.11.011","volume":"20","author":"Seelam N.","year":"2016","unstructured":"Seelam N.; Shrivastava S.P.; Prasanthi S.; Gupta S.; Synthesis and in vitro study of some fused 1, 2, 4-triazole derivatives as antimycobacterial agents. J Saudi Chem Soc 2016,20(4),411-418","journal-title":"J Saudi Chem Soc"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.carbpol.2016.01.007","volume":"142","author":"Tan W.","year":"2016","unstructured":"Tan W.; Li Q.; Wang H.; Synthesis, characterization, and antibacterial property of novel starch derivatives with 1,2,3-triazole. Carbohydr Polym 2016,142,1-7","journal-title":"Carbohydr Polym"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"Pii: 507","DOI":"10.3390\/molecules22040507","volume":"22","author":"Gen\u00e7er H.K.","year":"2017","unstructured":"Gen\u00e7er H.K.; \u00c7evik U.A.; Levent S.; New benzimidazole-1, 2, 4-triazole hybrid compounds: synthesis, anticandidal activity and cytotoxicity evaluation. Molecules 2017,22(4),Pii: 507","journal-title":"Molecules"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ijbiomac.2016.06.006","volume":"91","author":"Li Q.","year":"2016","unstructured":"Li Q.; Tan W.; Zhang C.; Gu G.; Guo Z.; Synthesis of water soluble chitosan derivatives with halogeno-1,2,3-triazole and their antifungal activity. Int J Biol Macromol 2016,91,623-629","journal-title":"Int J Biol Macromol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"521","DOI":"10.2174\/157018081306160618181757","volume":"13","author":"Zhai Z.W.","year":"2016","unstructured":"Zhai Z.W.; Shi Y.X.; Yang M.Y.; Microwave assisted synthesis and antifungal activity of some novel thioethers containing 1, 2, 4-triazolo[4, 3-a]pyridine moiety. Lett Drug Des Discov 2016,13(6),521-525","journal-title":"Lett Drug Des Discov"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1134\/S1068162016050022","volume":"42","author":"Alexandrova L.A.","year":"2016","unstructured":"Alexandrova L.A.; Efremenkova O.V.; Andronova V.L.; 5-(4-alkyl-1, 2, 3-triazol-1-yl)methyl derivatives of 2\u2032-deoxyuridine as inhibitors of viral and bacterial growth. Russ J Bioorganic Chem 2016,42(6),677-684","journal-title":"Russ J Bioorganic Chem"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"9194","DOI":"10.1039\/C5OB01025J","volume":"13","author":"Caraballo R.","year":"2015","unstructured":"Caraballo R.; Saleeb M.; Bauer J.; Triazole linker-based trivalent sialic acid inhibitors of adenovirus type 37 infection of human corneal epithelial cells. Org Biomol Chem 2015,13(35),9194-9205","journal-title":"Org Biomol Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1021\/acs.jmedchem.5b00327","volume":"58","author":"Vernekar S.K.V.","year":"2015","unstructured":"Vernekar S.K.V.; Qiu L.; Zhang J.; 5\u2032-Silylated 3\u2032-1, 2, 3-triazolyl thymidine analogs as inhibitors of west nile virus and dengue virus. J Med Chem 2015,58(9),4016-4028","journal-title":"J Med Chem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/ardp.201500292","volume":"349","author":"Ouahrouch A.","year":"2016","unstructured":"Ouahrouch A.; Taourirte M.; Schols D.; Design, synthesis, and antiviral activity of novel ribonucleosides of 1,2,3-triazolylbenzyl-aminophosphonates. Arch Pharm (Weinheim) 2016,349(1),30-41","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.pharma.2016.03.005","volume":"74","author":"Karrouchi K.","year":"2016","unstructured":"Karrouchi K.; Chemlal L.; Taoufik J.; Synthesis, antioxidant and analgesic activities of Schiff bases of 4-amino-1, 2, 4-triazole derivatives containing a pyrazole moiety. Ann Pharm Fr 2016,74(6),431-438","journal-title":"Ann Pharm Fr"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1039\/C6MD00216A","volume":"7","author":"Bahia S.B.B.","year":"2016","unstructured":"Bahia S.B.B.; Reis W.J.; Jardim G.A.; Molecular hybridization as a powerful tool towards multitarget quinoidal systems: synthesis, trypanocidal and antitumor activities of naphthoquinone-based 5-iodo-1, 4-disubstituted-, 1, 4-and 1, 5-disubstituted-1, 2, 3-triazoles. MedChemComm 2016,7(8),1555-1563","journal-title":"MedChemComm"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2174\/1871520615666150817115913","volume":"16","author":"Chen X.","year":"2016","unstructured":"Chen X.; Shi Y.M.; Huang C.; Xia S.; Yang L.J.; Yang X.D.; Novel dibenzo[b,d]furan-1H-1,2,4-triazole derivatives: synthesis and antitumor activity. Anticancer Agents Med Chem 2016,16(3),377-386","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"29103","DOI":"10.1039\/C7RA02720F","volume":"7","author":"Feng D.","year":"2017","unstructured":"Feng D.; Wu Y.; Wang H.; Synthesis and antiproliferative activity of 2-aryl-4-(3, 4, 5-trimethoxybenzoyl)-1, 2, 3-triazol derivatives as microtubule-destabilizing agents. RSC Advances 2017,7(46),29103-29111","journal-title":"RSC Advances"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.ejmech.2016.08.062","volume":"124","author":"Kraljevi\u0107 T.G.","year":"2016","unstructured":"Kraljevi\u0107 T.G.; Harej A.; Sedi\u0107 M.; Synthesis, in vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole-coumarin hybrids. Eur J Med Chem 2016,124,794-808","journal-title":"Eur J Med Chem"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.bmcl.2016.01.017","volume":"26","author":"Li B.L.","year":"2016","unstructured":"Li B.L.; Li B.; Zhang R.L.; Synthesis and antiproliferative evaluation of novel 1,2,4-triazole derivatives incorporating benzisoselenazolone scaffold. Bioorg Med Chem Lett 2016,26(4),1279-1281","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.3892\/ijo.2017.3912","volume":"50","author":"Mioc M.","year":"2017","unstructured":"Mioc M.; Soica C.; Bercean V.; Design, synthesis and pharmaco-toxicological assessment of 5-mercapto-1,2,4-triazole derivatives with antibacterial and antiproliferative activity. Int J Oncol 2017,50(4),1175-1183","journal-title":"Int J Oncol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.bmcl.2016.01.055","volume":"26","author":"Narsimha S.","year":"2016","unstructured":"Narsimha S.; Satheesh Kumar N.; Kumara Swamy B.; Vasudeva Reddy N.; Althaf Hussain S.K.; Srinivasa Rao M.; Indole-2-carboxylic acid derived mono and bis 1,4-disubstituted 1,2,3-triazoles: synthesis, characterization and evaluation of anticancer, antibacterial, and DNA-cleavage activities. Bioorg Med Chem Lett 2016,26(6),1639-1644","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.1016\/j.bmcl.2016.05.086","volume":"26","author":"Zhao P.L.","year":"2016","unstructured":"Zhao P.L.; Chen P.; Li Q.; Design, synthesis and biological evaluation of novel 3-alkylsulfanyl-4-amino-1,2,4-triazole derivatives. Bioorg Med Chem Lett 2016,26(15),3679-3683","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=68","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.201800076","volume":"351","author":"Sar\u0131kaya G.","year":"2018","unstructured":"Sar\u0131kaya G.; \u00c7oban G.; Parlar S.; Multifunctional cholinesterase inhibitors for Alzheimer\u2019s disease: synthesis, biological evaluations, and docking studies of o\/p-propoxyphenylsubstituted-1H-benzimidazole derivatives. Arch Pharm (Weinheim) 2018,351(8)","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1007\/s00044-017-1874-1","volume":"26","author":"Unsal-Tan O.","year":"2017","unstructured":"Unsal-Tan O.; Ozadali-Sari K.; Ayazgok B.; K\u00fc\u00e7\u00fckk\u0131l\u0131n\u00e7 T.T.; Balkan A.; Novel 2-Arylbenzimidazole derivatives as multi-targeting agents to treat Alzheimer\u2019s disease. Med Chem Res 2017,26(7),1506-1515","journal-title":"Med Chem Res"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.ejmech.2016.11.017","volume":"125","author":"Kim T.","year":"2017","unstructured":"Kim T.; Yang H.Y.; Park B.G.; Discovery of benzimidazole derivatives as modulators of mitochondrial function: a potential treatment for Alzheimer\u2019s disease. Eur J Med Chem 2017,125,1172-1192","journal-title":"Eur J Med Chem"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.ejmech.2016.11.021","volume":"125","author":"Tarazi H.","year":"2017","unstructured":"Tarazi H.; Odeh R.A.; Al-Qawasmeh R.; Yousef I.A.; Voelter W.; Al-Tel T.H.; Design, synthesis and SAR analysis of potent BACE1 inhibitors: possible lead drug candidates for Alzheimer\u2019s disease. Eur J Med Chem 2017,125,1213-1224","journal-title":"Eur J Med Chem"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ejmech.2016.09.093","volume":"126","author":"Singla P.","year":"2017","unstructured":"Singla P.; Luxami V.; Singh R.; Tandon V.; Paul K.; Novel pyrazolo[3,4-d]pyrimidine with 4-(1H-benzimidazol-2-yl)-phenylamine as broad spectrum anticancer agents: synthesis, cell based assay, topoisomerase inhibition, DNA intercalation and bovine serum albumin studies. Eur J Med Chem 2017,126,24-35","journal-title":"Eur J Med Chem"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ejmech.2017.11.037","volume":"144","author":"Cheong J.E.","year":"2018","unstructured":"Cheong J.E.; Zaffagni M.; Chung I.; Synthesis and anticancer activity of novel water soluble benzimidazole carbamates. Eur J Med Chem 2018,144,372-385","journal-title":"Eur J Med Chem"},{"key":"ref=74","doi-asserted-by":"publisher","DOI":"10.1002\/aoc.4185","volume":"32","author":"Pellei M.","year":"2018","unstructured":"Pellei M.; Gandin V.; Marzano C.; Marinelli M.; Del Bello F.; Santini C.; The first water-soluble copper (I) complexes bearing sulfonated imidazole-and benzimidazole-derived N-heterocyclic carbenes: synthesis and anticancer studies. Appl Organomet Chem 2018,32(3)","journal-title":"Appl Organomet Chem"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.3390\/molecules23102457","volume":"23","author":"Luo B.","year":"2018","unstructured":"Luo B.; Li D.; Zhang A-L.; Gao J-M.; Synthesis, antifungal activities and molecular docking studies of benzoxazole and benzothiazole derivatives. Molecules 2018,23(10),2457","journal-title":"Molecules"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1874844901805010001","volume":"5","author":"Sharma A.K.","year":"2018","unstructured":"Sharma A.K.; Sharma R.; Gangwal A.; Antifungal activities and characterization of some new environmentally safe Cu (ii) surfactants substituted 2-Amino-6-Methyl Benzothiazole. Open Pharm Sci J 2018,5(1),1-11","journal-title":"Open Pharm Sci J"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2174\/1874844901805010024","volume":"5","author":"Mathur N.","year":"2018","unstructured":"Mathur N.; Jain N.; Sharma A.K.; Biocidal activities of substituted benzothiazole of copper surfactants over candida albicans","journal-title":"Open Pharm Sci J"},{"key":"ref=78","doi-asserted-by":"crossref","first-page":"34","DOI":"10.14302\/issn.2328-0182.japst-18-2522","volume":"1","author":"Kumawat P.","year":"2018","unstructured":"Kumawat P.; Sharma R.; Sharma N.; Synthesis and analysis of copper neem (azadirechta indica) soap-nitro and ethoxy benzothiazole complexes for anti-bacterial activity related with skin diseases. J Adv Pharm Sci Tech 2018,1(4),34-46","journal-title":"J Adv Pharm Sci Tech"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1080\/09205063.2018.1429861","volume":"29","author":"Zhu W.","year":"2018","unstructured":"Zhu W.; Lao C.; Luo S.; Mechanical and antibacterial properties of benzothiazole-based dental resin materials. J Biomater Sci Polym Ed 2018,29(6),635-645","journal-title":"J Biomater Sci Polym Ed"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1016\/j.bmcl.2018.06.016","volume":"28","author":"Maddili S.K.","year":"2018","unstructured":"Maddili S.K.; Li Z-Z.; Kannekanti V.K.; Azoalkyl ether imidazo[2,1-b]benzothiazoles as potentially antimicrobial agents with novel structural skeleton. Bioorg Med Chem Lett 2018,28(14),2426-2431","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2174\/1568026618666180206101814","volume":"18","author":"Haroun M.","year":"2018","unstructured":"Haroun M.; Tratrat C.; Kositsi K.; New benzothiazole-based thiazolidinones as potent antimicrobial agents. Design, synthesis and biological evaluation. Curr Top Med Chem 2018,18(1),75-87","journal-title":"Curr Top Med Chem"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2174\/1570180812666150821003220","volume":"13","author":"Singh M.","year":"2016","unstructured":"Singh M.; Singh S.K.; Gangwar M.; Sellamuthu S.; Nath G.; Singh S.K.; Design, synthesis and mode of action of some new 2-(4\u2032-aminophenyl)benzothiazole derivatives as potent antimicrobial agents. Lett Drug Des Discov 2016,13(5),429-437","journal-title":"Lett Drug Des Discov"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1021\/acs.jmedchem.8b02021","volume":"62","author":"Linciano P.","year":"2019","unstructured":"Linciano P.; Pozzi C.; Iacono L.D.; Enhancement of benzothiazoles as pteridine reductase-1(PTR1) inhibitors for the treatment of trypanosomatidic infections. J Med Chem 2019,62(8),3989-4012","journal-title":"J Med Chem"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s11030-018-9830-7","volume":"22","author":"S\u00e1nchez-Salgado J.C.","year":"2018","unstructured":"S\u00e1nchez-Salgado J.C.; Bilbao-Ramos P.; Dea-Ayuela M.A.; Systematic search for benzimidazole compounds and derivatives with antileishmanial effects. Mol Divers 2018,22(4),779-790","journal-title":"Mol Divers"}],"container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/176938","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,8]],"date-time":"2020-02-08T05:45:37Z","timestamp":1581140737000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/176938\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,9]]},"references-count":84,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2020,1,9]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612825666191125090700","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1,9]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-06-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}